Midas Fertchem Impex Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.00 M
- Revenue Growth 9.01%
- Profit Growth 88.12%
- Ebitda 60.17%
- Net Worth 54.55%
- Total Assets 0.52%
About Midas Fertchem Impex
Midas Fertchem Impex Private Limited (MFIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 May 2012 and has a history of 12 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manish Jain, Ritik Jain, and Rashmi Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2012PTC235720
- Company No.
235720
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2012
- Date of AGM
14 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Midas Fertchem Impex?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritik Jain  | Director | 06-Sep-2021 | Current |
| Manish Jain | Whole-Time Director | 11-May-2012 | Current |
| Rashmi Jain | Whole-Time Director | 11-May-2012 | Current |
Financial Performance of Midas Fertchem Impex.
Midas Fertchem Impex Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 9.01% increase. The company also saw a substantial improvement in profitability, with a 88.12% increase in profit. The company's net worth Soared by an impressive increase of 54.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Midas Fertchem Impex?
In 2020, Midas Fertchem Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹8.00 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2018 | Axis Bank Limited | ₹8.00 M | Satisfied |
How Many Employees Work at Midas Fertchem Impex?
Unlock and access historical data on people associated with Midas Fertchem Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Midas Fertchem Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Midas Fertchem Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
